Hepatocellular carcinoma (HCC) is the most common type of primary liver cancer in adults and is currently the most common cause of death in people with... 86 KB (9,623 words) - 09:20, 3 April 2024 |
Liver cancer (redirect from Liver carcinoma) Asia and sub-Saharan Africa. Males are more often affected with hepatocellular carcinoma (HCC) than females. Diagnosis is most frequent among those 55 to... 57 KB (6,092 words) - 19:57, 20 April 2024 |
Cirrhosis (section Hepatocellular carcinoma) underlying portal hypertension. Ultrasound may also screen for hepatocellular carcinoma and portal hypertension. This is done by assessing flow in the... 107 KB (11,119 words) - 05:17, 25 April 2024 |
Cholangiocarcinoma (redirect from Bile duct carcinoma) and may be used to help differentiate a cholangiocarcinoma from hepatocellular carcinoma and metastasis of other gastrointestinal tumors. Cytological scrapings... 74 KB (7,639 words) - 03:55, 13 January 2024 |
K. A 1984 study first described the use of DCP as a marker of hepatocellular carcinoma (HCC); it was present in 91% of HCC patients, while not being detectable... 4 KB (561 words) - 18:16, 10 June 2021 |
Basal-cell carcinoma (BCC), also known as basal-cell cancer, basalioma or rodent ulcer, is the most common type of skin cancer. It often appears as a... 53 KB (5,218 words) - 00:37, 13 March 2024 |
Proton therapy (section Hepatocellular carcinoma) following review presents the benefits of proton therapy in treating hepatocellular carcinoma, pancreatic cancer and esophageal cancer. Post-treatment liver... 108 KB (9,850 words) - 09:42, 8 April 2024 |
Regorafenib (section Advanced hepatocellular carcinoma) Excellence (NICE) approved use of regorafenib in patients with advanced hepatocellular carcinoma who were previously treated with sorafenib. MetastaticCRC: After... 9 KB (853 words) - 21:36, 20 December 2023 |
secrete AFP are endodermal sinus tumor (yolk sac carcinoma), hepatoblastoma, and hepatocellular carcinoma.In patients with AFP-secreting tumors, serum levels... 17 KB (2,195 words) - 23:37, 7 November 2023 |
ambiguous and cannot always establish a differential diagnosis with hepatocellular carcinoma. Thus, during the arterial phase there is a centripetal and inhomogeneous... 48 KB (5,451 words) - 23:54, 26 October 2023 |
was identified as a bioactive chemotherapeutic agent, against hepatocellular carcinoma, obtained from the methanolic extract of S. nigrum. Lankalapalli... 34 KB (3,791 words) - 08:10, 24 March 2024 |
year will likely progress to hepatocellular carcinoma. Worldwide, the estimated prevalence of hepatocellular carcinoma related to NAFLD is 15–30%. NASH... 164 KB (16,800 words) - 01:47, 21 April 2024 |
EMP3 (section Hepatocellular carcinoma (HCC)) promoter regions of EMP3 being hypermethylated or unmethylated. Hepatocellular carcinoma (HCC), which is mainly caused by the chronic infections of hepatitis... 10 KB (1,145 words) - 00:38, 19 August 2023 |
ADAR (section Hepatocellular carcinoma) RNA editing sites can be found here. Studies of patients with hepatocellular carcinoma (HCC) have shown trends of upregulated ADAR1 and downregulated... 38 KB (4,802 words) - 18:44, 25 April 2024 |
incidence of hepatocellular carcinoma (HCC; liver cancer). Across Europe, hepatitis B and C cause approximately 50% of hepatocellular carcinomas. Chronic... 84 KB (9,293 words) - 02:23, 8 April 2024 |
Cutaneous squamous-cell carcinoma (cSCC), also known as squamous-cell carcinoma of the skin or squamous-cell skin cancer, is one of the three principal... 53 KB (5,400 words) - 19:22, 12 March 2024 |